Literature DB >> 22595516

The pertussis epidemic: informing strategies for prevention of severe disease.

M F Clarke1, K Rasiah1, J Copland2, M Watson2, A P Koehler2, K Dowling3, H S Marshall1.   

Abstract

To assess the impact of Bordetella pertussis infections in South Australia during an epidemic and determine vulnerable populations, data from notification reports for pertussis cases occurring between July 2008 and December 2009 were reviewed to determine the distribution of disease according to specific risk factors and examine associations with hospitalizations. Although the majority (66%) of the 6230 notifications for pertussis occurred in adults aged >24 years, the highest notification and hospitalization rate occurred in infants aged <1 year. For these infants, factors associated with hospitalization included being aged <2 months [relative risk (RR) 2·3, 95% confidence interval (CI) 1·60-3·32], Indigenous ethnicity (RR 1·7, 95% CI 1·03-2·83) and receiving fewer than two doses of pertussis vaccine (RR 4·1, 95% CI 1·37-12·11). A combination of strategies aimed at improving direct protection for newborns, vaccination for the elderly, and reducing transmission from close contacts of infants are required for prevention of severe pertussis disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22595516      PMCID: PMC9152035          DOI: 10.1017/S095026881200091X

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  8 in total

1.  Intensity of exposure and severity of whooping cough.

Authors:  N M Nielsen; K Hedegaard; P Aaby
Journal:  J Infect       Date:  2001-10       Impact factor: 6.072

2.  Immunisation coverage annual report, 2008.

Authors:  Brynley P Hull; Deepika Mahajan; Aditi Dey; Rob I Menzies; Peter B McIntyre
Journal:  Commun Dis Intell Q Rep       Date:  2010-09

3.  Higher pertussis hospitalization rates in indigenous Australian infants, and delayed vaccination.

Authors:  Veronica Kolos; Robert Menzies; Peter McIntyre
Journal:  Vaccine       Date:  2006-08-31       Impact factor: 3.641

4.  Pertussis epidemiology in Australia over the decade 1995-2005--trends by region and age group.

Authors:  Helen E Quinn; Peter B McIntyre
Journal:  Commun Dis Intell Q Rep       Date:  2007-06

5.  The seroepidemiology of pertussis in Australia during an epidemic period.

Authors:  M Cagney; C R MacIntyre; P McIntyre; M Puech; A Giammanco
Journal:  Epidemiol Infect       Date:  2006-05-11       Impact factor: 2.451

6.  Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age.

Authors:  Nicholas Wood; Peter McIntyre; Helen Marshall; Don Roberton
Journal:  Pediatr Infect Dis J       Date:  2010-03       Impact factor: 2.129

7.  Effectiveness of acellular pertussis vaccine assessed by hospital-based active surveillance in Germany.

Authors:  P Juretzko; R von Kries; M Hermann; C H Wirsing von König; J Weil; G Giani
Journal:  Clin Infect Dis       Date:  2002-06-19       Impact factor: 9.079

8.  Effects of pertussis vaccination on disease: vaccine efficacy in reducing clinical severity.

Authors:  Marie-Pierre Préziosi; M Elizabeth Halloran
Journal:  Clin Infect Dis       Date:  2003-08-23       Impact factor: 9.079

  8 in total
  6 in total

1.  Descriptive Overview of Pertussis Epidemiology Among Older Adults in Europe During 2010-2020.

Authors:  Enas Bahar; Daria Shamarina; Yan Sergerie; Piyali Mukherjee
Journal:  Infect Dis Ther       Date:  2022-07-06

2.  Serodiagnosis as adjunct assay for pertussis infection in São Paulo, Brazil.

Authors:  Lourdes R A Vaz-de-Lima; Monte D Martin; Lucia C Pawloski; Daniela Leite; Karen C P Rocha; Cyro A de Brito; Tânia M I Vaz; Luciano Moura Martins; Danielly P Alvarenga; Ana F Ribeiro; Telma R M P Carvalhanas; Rosa M D Nakasaki; Silvia S Oliveira; Eliseu A Waldman; Maria Lucia Tondella
Journal:  Clin Vaccine Immunol       Date:  2014-03-05

3.  Antibodies to Bordetella pertussis antigens in maternal and cord blood pairs: a Thai cohort study.

Authors:  Nasamon Wanlapakorn; Thanunrat Thongmee; Preeyaporn Vichaiwattana; Elke Leuridan; Sompong Vongpunsawad; Yong Poovorawan
Journal:  PeerJ       Date:  2017-11-23       Impact factor: 2.984

4.  Time series modeling of pertussis incidence in China from 2004 to 2018 with a novel wavelet based SARIMA-NAR hybrid model.

Authors:  Yongbin Wang; Chunjie Xu; Zhende Wang; Shengkui Zhang; Ying Zhu; Juxiang Yuan
Journal:  PLoS One       Date:  2018-12-26       Impact factor: 3.240

5.  Is adding maternal vaccination to prevent whooping cough cost-effective in Australia?

Authors:  Laure-Anne Van Bellinghen; Alex Dimitroff; Michael Haberl; Xiao Li; Andrew Manton; Karen Moeremans; Nadia Demarteau
Journal:  Hum Vaccin Immunother       Date:  2018-06-22       Impact factor: 3.452

6.  Pertussis in high-risk groups: an overview of the past quarter-century.

Authors:  Victoria A Jenkins; Miloje Savic; Walid Kandeil
Journal:  Hum Vaccin Immunother       Date:  2020-04-16       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.